pediatric-chronic
Juvenile Arthritis in Children: Signs, Diagnosis, and Daily Life
Juvenile arthritis (JIA) is immune-driven joint inflammation in children. Signs: joint swelling, morning stiffness, warm joints. Managed with medication, physical therapy, and regular eye exams to monitor for silent uveitis.
Talk to a clinician
Lena Park, PNP — Pediatric NP
kids & families. Gale can match you with a licensed clinician for a visit.
Find care →What Is Juvenile Idiopathic Arthritis?
Juvenile idiopathic arthritis (JIA) is an umbrella term for several types of persistent inflammatory arthritis that begin before age 16 and last at least six weeks 1Ref 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2023).Juvenile Idiopathic Arthritis — Research & Resources.JIA definition, subtypes, immune-mediated mechanism, uveitis screening requirement, and many children achieving long-term remission with treatment. 'Idiopathic' means the exact cause is unknown, though the conditions share an immune system that attacks the body's own joint tissues rather than external threats. JIA is not contagious and is not caused by injury or sports. There are several distinct subtypes: oligoarticular JIA affects four or fewer joints (the most common subtype); polyarticular JIA affects five or more joints; and systemic JIA involves the whole body with recurring fever, rash, and joint inflammation 1Ref 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2023).Juvenile Idiopathic Arthritis — Research & Resources.JIA definition, subtypes, immune-mediated mechanism, uveitis screening requirement, and many children achieving long-term remission with treatment2Ref 2American College of Rheumatology (2021).Juvenile Idiopathic Arthritis Clinical Practice Guidelines.Diagnostic criteria (6 weeks of symptoms), treatment options including biologics and disease-modifying agents, and uveitis screening protocols by JIA subtype. A pediatric rheumatologist distinguishes the subtypes, which matters substantially for treatment choice and long-term outlook.
Signs to Look for in a Child
Common signs include joint swelling (a joint looks puffy or larger than usual), warmth in the joint, stiffness that is worst in the morning or after resting and loosens up with movement, and limping or guarding a limb — especially in young children who may not be able to say what hurts 1Ref 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2023).Juvenile Idiopathic Arthritis — Research & Resources.JIA definition, subtypes, immune-mediated mechanism, uveitis screening requirement, and many children achieving long-term remission with treatment. Pain level varies; some children with visible swelling report little pain. A rash and fever together with joint symptoms may point to systemic JIA, which warrants prompt evaluation 2Ref 2American College of Rheumatology (2021).Juvenile Idiopathic Arthritis Clinical Practice Guidelines.Diagnostic criteria (6 weeks of symptoms), treatment options including biologics and disease-modifying agents, and uveitis screening protocols by JIA subtype. Eye inflammation (uveitis) can occur with some JIA types with few or no eye symptoms, which is why regular eye screenings are part of care 3Ref 3Arthritis Foundation (2024).Juvenile Idiopathic Arthritis.Uveitis as a silent complication requiring ophthalmologic slit-lamp screening; physical and occupational therapy as core JIA management; remission outcomes.
How Is JIA Diagnosed?
There is no single test for JIA. Diagnosis involves a careful history, physical examination, blood tests (including inflammatory markers and sometimes ANA), and imaging to rule out other causes of joint symptoms — infection, injury, and other conditions can look similar 2Ref 2American College of Rheumatology (2021).Juvenile Idiopathic Arthritis Clinical Practice Guidelines.Diagnostic criteria (6 weeks of symptoms), treatment options including biologics and disease-modifying agents, and uveitis screening protocols by JIA subtype. Symptoms must be present for at least six weeks before JIA can be formally diagnosed. A pediatric rheumatologist typically confirms the diagnosis and leads ongoing care, often alongside the child's pediatrician 1Ref 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2023).Juvenile Idiopathic Arthritis — Research & Resources.JIA definition, subtypes, immune-mediated mechanism, uveitis screening requirement, and many children achieving long-term remission with treatment.
Treatment: The Goal Is Remission and Function
Treatment aims to control inflammation, prevent joint damage, relieve symptoms, and help the child stay physically active. Depending on the type and severity, options may include non-steroidal anti-inflammatory drugs (NSAIDs), intraarticular corticosteroid injections, disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, or biologic therapies targeting specific inflammatory pathways 2Ref 2American College of Rheumatology (2021).Juvenile Idiopathic Arthritis Clinical Practice Guidelines.Diagnostic criteria (6 weeks of symptoms), treatment options including biologics and disease-modifying agents, and uveitis screening protocols by JIA subtype. The 2021 ACR guidelines recommend oral over subcutaneous methotrexate as an update to prior standard of care, and emphasize decreased reliance on systemic glucocorticoids 2Ref 2American College of Rheumatology (2021).Juvenile Idiopathic Arthritis Clinical Practice Guidelines.Diagnostic criteria (6 weeks of symptoms), treatment options including biologics and disease-modifying agents, and uveitis screening protocols by JIA subtype. Many children with JIA achieve long-term remission with treatment; some eventually taper off medication entirely 1Ref 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2023).Juvenile Idiopathic Arthritis — Research & Resources.JIA definition, subtypes, immune-mediated mechanism, uveitis screening requirement, and many children achieving long-term remission with treatment3Ref 3Arthritis Foundation (2024).Juvenile Idiopathic Arthritis.Uveitis as a silent complication requiring ophthalmologic slit-lamp screening; physical and occupational therapy as core JIA management; remission outcomes. Physical and occupational therapy are core components — they help maintain joint range of motion, muscle strength, and daily function, especially during or after flares. Regular eye exams are built into the care schedule because uveitis can silently affect vision 3Ref 3Arthritis Foundation (2024).Juvenile Idiopathic Arthritis.Uveitis as a silent complication requiring ophthalmologic slit-lamp screening; physical and occupational therapy as core JIA management; remission outcomes.
The Silent Eye Risk: Uveitis Screening
Children with certain JIA subtypes — particularly oligoarticular JIA with ANA positivity — face a significant risk of uveitis (inflammation inside the eye) that causes no redness or pain in its early stages 3Ref 3Arthritis Foundation (2024).Juvenile Idiopathic Arthritis.Uveitis as a silent complication requiring ophthalmologic slit-lamp screening; physical and occupational therapy as core JIA management; remission outcomes. Left undetected, it can cause vision loss. This is why regular slit-lamp eye exams by an ophthalmologist are a non-negotiable part of JIA care, even when a child's eyes seem perfectly fine 3Ref 3Arthritis Foundation (2024).Juvenile Idiopathic Arthritis.Uveitis as a silent complication requiring ophthalmologic slit-lamp screening; physical and occupational therapy as core JIA management; remission outcomes. The frequency of screening depends on the JIA subtype and ANA status. The ACR JIA guidelines include specific uveitis screening protocols 2Ref 2American College of Rheumatology (2021).Juvenile Idiopathic Arthritis Clinical Practice Guidelines.Diagnostic criteria (6 weeks of symptoms), treatment options including biologics and disease-modifying agents, and uveitis screening protocols by JIA subtype.
Supporting a Child with JIA at Home and School
Mornings can be the hardest time — a warm bath or shower, gentle range-of-motion movement, and a few extra minutes to get ready can help ease stiffness before school. Exercise and activity are actively encouraged rather than avoided; low-impact activities like swimming, cycling, and walking are generally well tolerated and beneficial for joint health. The care team can help adapt a school accommodation plan for days when stiffness, pain, fatigue, or medical appointments interfere. A 504 plan or health accommodation can cover extra time for assignments on difficult days, permission to stand or change positions, access to an elevator, and PE modifications during flares. The emotional weight of chronic pain and being different from peers can be significant — children with JIA have higher rates of anxiety and depression than peers, and psychological support is a meaningful part of comprehensive care 1Ref 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2023).Juvenile Idiopathic Arthritis — Research & Resources.JIA definition, subtypes, immune-mediated mechanism, uveitis screening requirement, and many children achieving long-term remission with treatment. Connecting with pediatric arthritis support organizations can be helpful for both children and parents.
Common questions
Is juvenile arthritis the same as adult arthritis?
No. Juvenile idiopathic arthritis is an immune-mediated inflammatory condition that begins in childhood. Adult osteoarthritis is related to wear and aging. They are different conditions with different causes and treatments.
Will my child always have arthritis?
Outcomes vary by JIA type. Some children achieve long-term remission and the condition does not continue into adulthood. Others have ongoing disease. A pediatric rheumatologist can give the most accurate picture for a specific child's subtype.
Can a child with JIA play sports?
In most cases, yes — staying active is encouraged. The care team can advise on which activities are safe based on which joints are affected. High-impact contact sports may be limited during flares.
Why does my child need eye exams if their eyes seem fine?
Uveitis (eye inflammation) can occur silently in some JIA subtypes, causing damage without pain or redness. Regular slit-lamp exams by an ophthalmologist catch it early, when it is easiest to treat.
Talk to a clinician
Lena Park, PNP — Pediatric NP
kids & families. Gale can match you with a licensed clinician for a visit.
Find care →When to get care right away
- —Sudden severe joint pain or swelling that is very different from usual
- —High fever with a salmon-colored rash and joint swelling (possible systemic JIA flare)
- —Eye pain, redness, or vision changes at any time
- —Child cannot bear weight on a limb
- —Signs of joint infection: hot, swollen joint with fever — this requires urgent evaluation to distinguish from an arthritis flare
Seek emergency care for a child with a hot, swollen joint and fever who appears very ill — septic arthritis is a medical emergency. Go to the ED or call 911.
This article is general health information for parents, not a diagnosis or treatment plan for any child. All management decisions should be made with a pediatric rheumatologist and the child's care team.
References
- 1.National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2023). Juvenile Idiopathic Arthritis — Research & Resources. NIAMS Health Topics. link ✓JIA definition, subtypes, immune-mediated mechanism, uveitis screening requirement, and many children achieving long-term remission with treatment
- 2.American College of Rheumatology (2021). Juvenile Idiopathic Arthritis Clinical Practice Guidelines. American College of Rheumatology. link ✓Diagnostic criteria (6 weeks of symptoms), treatment options including biologics and disease-modifying agents, and uveitis screening protocols by JIA subtype
- 3.Arthritis Foundation (2024). Juvenile Idiopathic Arthritis. Arthritis Foundation Health Resources. link ✓Uveitis as a silent complication requiring ophthalmologic slit-lamp screening; physical and occupational therapy as core JIA management; remission outcomes
3 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.